NCT06974110 2026-01-16
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
Phase 1 Recruiting
MOMA Therapeutics
Shandong Cancer Hospital and Institute
City of Hope Medical Center
Anhui Provincial Hospital
Persephone Biosciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Chao Yang Hospital